BICO News Feed
Discover the latest news from our business areas.
The US senate has passed the FDA Modernization Act
The US Senate has passed the FDA Modernization Act with unanimous consent!
A massive stride in the acceptance of alternatives to animal models in drug discovery. Alternatives that capture human physiology better, that are more ethical, sustainable and most importantly, alternatives that can accelerate the discovery of life changing therapies. Alternatives that our bioprinters have proudly supported and enabled since our inception. Alternatives that we are committed to continuing to develop and democratize.
February 27, 2023 | Scienion
BICO introduces new life sciences manufacturing platform integrating ABB Robotics technology
February 27, 2023 | Cellink
CELLINK and Nanyang Technological University jointly open a Research, Innovation and Development Lab focused on exploring bioprinting in critical use cases like regenerative medicine and drug discovery.
February 14, 2023 | Cellink
CELLINK Introduces DNA Studio 4 Vault, a bioprinting software developed to support our customers to adhere to Title 21 CFR Part 11 Electronic records and EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines – Chapter 4: Documentation
February 6, 2023 | Scienion
SCIENION expects to move to its new building in Wagner-Régeny-Straße in Berlin Adlershof in June 2023